We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aeterna Zentaris Inc | NASDAQ:AEZS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0025 | -0.13% | 1.95 | 1.88 | 2.28 | 2.07 | 1.95 | 1.95 | 19,325 | 22:16:11 |
Name of Nominee | Votes For | % | Votes Withheld | % |
Carolyn Egbert | 1,867,049 | 91.19 | 180,324 | 8.81 |
Gérard Limoges | 1,861,389 | 90.92 | 185,984 | 9.08 |
Robin Smith Hoke | 1,864,981 | 91.09 | 182,392 | 8.91 |
Brent Norton | 1,861,563 | 90.92 | 185,810 | 9.08 |
Jonathan Pollack | 1,860,317 | 90.86 | 187,056 | 9.14 |
The Company would like to extend its sincere thanks and best wishes to Juergen Ernst, who has served on the board of directors since 2005.
The Company reports the re-appointment of PricewaterhouseCoopers LLP as the Company's independent auditor.
The Company’s shareholders approved an ordinary resolution approving the amended and restated shareholder rights plan.
Further, the Company passed a special resolution to amend the articles of the corporation to change the province in which its registered office is situated from Quebec to Ontario.
For full voting details please see the voting results of Aeterna Zentaris Inc. as filed on SEDAR at www.sedar.com and EDGAR at www.sec.gov.
About Aeterna Zentaris Inc.
Aeterna Zentaris Inc. is a specialty biopharmaceutical company focused on commercializing novel pharmaceutical therapies, principally through out-licensing arrangements. Aeterna Zentaris is a party to a license and assignment agreement with Novo Nordisk A/S to carry out development, manufacturing, registration and commercialization of Macrilen™ (macimorelin) in the United States and Canada. For more information, visit www.zentaris.com.
Contacts:
Aeterna Zentaris Inc.Leslie AuldChief Financial OfficerIR@aezsinc.com (843) 900-3211
1 Year Aeterna Zentaris Chart |
1 Month Aeterna Zentaris Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions